These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2679087)

  • 1. Propafenone--a new agent for the treatment of ventricular arrhythmias.
    Grubb BP
    Am J Med Sci; 1989 Oct; 298(4):249-51. PubMed ID: 2679087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.
    Bryson HM; Palmer KJ; Langtry HD; Fitton A
    Drugs; 1993 Jan; 45(1):85-130. PubMed ID: 7680987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical use of class IC antiarrhythmic drugs.
    Abi Samra F
    J La State Med Soc; 1989 May; 141(5):27-31. PubMed ID: 2499646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propafenone in the treatment of cardiac arrhythmias. A risk-benefit appraisal.
    Capucci A; Boriani G
    Drug Saf; 1995 Jan; 12(1):55-72. PubMed ID: 7741984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class IC drugs: propafenone and flecainide.
    Puech P; Gagnol JP
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():549-53. PubMed ID: 2125832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.
    Harron DW; Brogden RN
    Drugs; 1987 Dec; 34(6):617-47. PubMed ID: 3322781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Washout of long-term treatment with flecainide and propafenone in patients with complex ventricular arrhythmias and cardiac disease. Antiarrhythmic Drug Evaluation Group.
    Vincenti A; Landolina M; Latini R; Cavalli A; Gaita F; Giani P
    Am Heart J; 1992 Aug; 124(2):374-80. PubMed ID: 1636581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propafenone: a new antiarrhythmic agent.
    Somberg JC; Tepper D; Landau S
    Am Heart J; 1988 Jun; 115(6):1274-9. PubMed ID: 3287873
    [No Abstract]   [Full Text] [Related]  

  • 10. Sustained therapeutic efficacy and safety of oral propafenone for treatment of chronic ventricular arrhythmias: a 2-year experience.
    Dinh H; Baker BJ; de Soyza N; Murphy ML
    Am Heart J; 1988 Jan; 115(1 Pt 1):92-6. PubMed ID: 3336989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propafenone for cardiac arrhythmias.
    Med Lett Drugs Ther; 1990 Apr; 32(816):37-8. PubMed ID: 2182990
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiarrhythmic propafenone: improving patient outcomes.
    Brzozowski LA
    Dimens Crit Care Nurs; 1993; 12(3):116-22. PubMed ID: 8508716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Propafenone--a promising anti-arrhythmia agent?].
    Rozsíval V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1990; 33(4):359-63. PubMed ID: 2130480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update: cardiac antiarrhythmic drugs.
    Liem LB; Kates RE
    Compr Ther; 1989 Apr; 15(4):17-27. PubMed ID: 2495883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propafenone: a promising new antiarrhythmic agent.
    Shen EN
    Chest; 1990 Aug; 98(2):434-41. PubMed ID: 2198142
    [No Abstract]   [Full Text] [Related]  

  • 16. A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.).
    Eur Heart J; 1992 Sep; 13(9):1251-8. PubMed ID: 1396837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moricizine: a new agent for the treatment of ventricular arrhythmias.
    Grubb BP
    Am J Med Sci; 1991 Jun; 301(6):398-401. PubMed ID: 2039027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propafenone (rythmol) for ventricular arrhythmias.
    Porterfield LM
    Adv Clin Care; 1990; 5(5):41. PubMed ID: 2393507
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of Org 7797 on early, late and inducible arrhythmias following coronary artery occlusion in rats and dogs.
    Winslow E; Campbell JK; Barron E; Marshall RJ; Muir AW
    Br J Pharmacol; 1991 Dec; 104(4):853-8. PubMed ID: 1810599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New drugs in the management of ventricular arrhythmias.
    Sanna GP
    G Ital Cardiol; 1984 Oct; 14(10):788-97. PubMed ID: 6083894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.